Advertisement
| curative new berlin therapies: Human Genome Editing National Academies of Sciences, Engineering, and Medicine, National Academy of Medicine, National Academy of Sciences, Committee on Human Gene Editing: Scientific, Medical, and Ethical Considerations, 2017-08-13 Genome editing is a powerful new tool for making precise alterations to an organism's genetic material. Recent scientific advances have made genome editing more efficient, precise, and flexible than ever before. These advances have spurred an explosion of interest from around the globe in the possible ways in which genome editing can improve human health. The speed at which these technologies are being developed and applied has led many policymakers and stakeholders to express concern about whether appropriate systems are in place to govern these technologies and how and when the public should be engaged in these decisions. Human Genome Editing considers important questions about the human application of genome editing including: balancing potential benefits with unintended risks, governing the use of genome editing, incorporating societal values into clinical applications and policy decisions, and respecting the inevitable differences across nations and cultures that will shape how and whether to use these new technologies. This report proposes criteria for heritable germline editing, provides conclusions on the crucial need for public education and engagement, and presents 7 general principles for the governance of human genome editing. |
| curative new berlin therapies: Gene Therapy for Viral Infections Patrick Arbuthnot, 2015-06-01 Gene Therapy for Viral Infections provides a comprehensive review of the broader field of nucleic acid and its use in treating viral infections. The text bridges the gap between basic science and important clinical applications of the technology, providing a systematic, integrated review of the advances in nucleic acid-based antiviral drugs and the potential advantages of new technologies over current treatment options. Coverage begins with the fundamentals, exploring varying topics, including harnessing RNAi to silence viral gene expression, antiviral gene editing, viral gene therapy vectors, and non-viral vectors. Subsequent sections include detailed coverage of the developing use of gene therapy for the treatment of specific infections, the principles of rational design of antivirals, and the hurdles that currently face the further advancement of gene therapy technology. - Provides coverage of gene therapy for a variety of infections, including HBV, HCV, HIV, hemorrhagic fever viruses, and respiratory and other viral infections - Bridges the gap between the basic science and the important medical applications of this technology - Features a broad approach to the topic, including an essential overview and the applications of gene therapy, synthetic RNA, and other antiviral strategies that involve nucleic acid engineering - Presents perspectives on the future use of nucleic acids as a novel class of antiviral drugs - Arms the reader with the cutting-edge information needed to stay abreast of this developing field |
| curative new berlin therapies: The Practice of Functional Analytic Psychotherapy Jonathan W. Kanter, Mavis Tsai, Robert J. Kohlenberg, 2010-06-14 Since the earliest years of its development, Functional Analytic Psychotherapy (FAP) has been hailed for its clinical innovation and transformative power with clients across the range of disorders. Building on the foundations of their earlier volumes about this versatile therapy, the editors of The Practice of Functional Analytic Psychotherapy bring together noted clinicians and researchers to explain in depth how FAP can be used in conjunction with a broad spectrum of therapeutic approaches, and with diverse client populations. The hallmarks of the method, including therapist sensitivity and responding to client behavior in the moment, courage, mindfulness, acceptance, and egalitarianism, inform a wide array of interventions and strategies, among them: Integrating FAP with other treatments, including cognitive behavioral therapy, acceptance and commitment therapy, dialectical behavior therapy, behavioral activation, psychodynamic therapies, and feminist therapies. Applying FAP across cultures, nationalities, and ethnicities. Employing FAP with couples. Increasing sensitivity to and effectiveness with sexual minority clients. Modifying FAP for developmentally appropriate use with adolescents. Enhancing a team approach with severely mentally ill patients in institutional settings. Strengthening the power of interpersonal process groups. As a new tool or an enhancement to current practice, these applications of FAP will give therapists an empowering complement to their work. The Practice of Functional Analytic Psychotherapy points to compelling directions in personal growth and change—on both sides of the therapeutic bond. |
| curative new berlin therapies: Human Herpesviruses Ann Arvin, Gabriella Campadelli-Fiume, Edward Mocarski, Patrick S. Moore, Bernard Roizman, Richard Whitley, Koichi Yamanishi, 2007-08-16 This comprehensive account of the human herpesviruses provides an encyclopedic overview of their basic virology and clinical manifestations. This group of viruses includes human simplex type 1 and 2, Epstein–Barr virus, Kaposi's Sarcoma-associated herpesvirus, cytomegalovirus, HHV6A, 6B and 7, and varicella-zoster virus. The viral diseases and cancers they cause are significant and often recurrent. Their prevalence in the developed world accounts for a major burden of disease, and as a result there is a great deal of research into the pathophysiology of infection and immunobiology. Another important area covered within this volume concerns antiviral therapy and the development of vaccines. All these aspects are covered in depth, both scientifically and in terms of clinical guidelines for patient care. The text is illustrated generously throughout and is fully referenced to the latest research and developments. |
| curative new berlin therapies: Oncologic Therapies Everett E. Vokes, Harvey M. Golomb, 2011-06-28 This second edition has been updated in a user-friendly layout that makes its comprehensive information extremely accessible. The handbook, written for all physicians who treat cancer patients, provides a survey of current therapeutic concepts of solid tumors and hematologic malignancies in internal oncology. Each individual chapter of this shortened new edition is structured in the same way and features a brief outline or tabular summary of the main aspects of epidemiology, pathology, staging, and diagnosis. The main focus is on the therapeutic strategy, i.e., an interdisciplinary approach to systemic drug therapy. Surgical and radiological concepts of treatment are also covered, as are supportive care, pain relief methods and ethical problems. This title is a must for clinicians and practitioners as well as interns, residents and postgraduate students. |
| curative new berlin therapies: Childhood Acute Lymphoblastic Leukemia Ajay Vora, 2017-04-21 This book provides a comprehensive and up-to-date review of all aspects of childhood Acute Lymphoblastic Leukemia, from basic biology to supportive care. It offers new insights into the genetic pre-disposition to the condition and discusses how response to early therapy and its basic biology are utilized to develop new prognostic stratification systems and target therapy. Readers will learn about current treatment and outcomes, such as immunotherapy and targeted therapy approaches. Supportive care and management of the condition in resource poor countries are also discussed in detail. This is an indispensable guide for research and laboratory scientists, pediatric hematologists as well as specialist nurses involved in the care of childhood leukemia. |
| curative new berlin therapies: Bone Cancer Dominique Heymann, 2009-08-20 The epidemiological and clinical importance of bone metastasis has long been recognized, but the past decade has seen an explosion in the fields of bone biology and bone cancer research. This period of time has been marked by a number of key discoveries that have led to the opening up of entirely new areas for investigation as well as new therapies which combine surgery and biological therapeutic approaches.Bone is a common site of cancer metastases - cancer cells commonly develop in bone and spread to other organ systems through the bloodstream. For example, the incidence of bone metastases in breast and prostate cancers is 70%, whereas it is only 30 to 40% in metastatic lung cancer. In clinical terms, bone metastases have substantial negative effects on a patient's quality of life and are a main cause of patient mortality. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for the medical and cancer research communities. This book provides, all in one resource, the most recent data on bone cancer development (cellular and molecular mechanisms), genomic and proteomic analyses, clinical analyses (histopathology, imaging, pain monitoring), as well as new therapeutic approaches and clinical trials for primary bone tumors and bone metastases. Feature - Presents a comprehensive, translational source for all aspects of bone cancer in one reference work - Bone cancer experts (from all areas of research and practice) take readers from the bench research (cellular and molecular mechanism), through genomic and proteomic analysis, all the way to clinical analysis (histopathology and imaging) and new therapeutic approaches. - Clear presentation by bone biologists of the cellular and molecular mechanisms underlying bone tumors and bone cancer metastasis as well as the genomic and proteomic assays used in detecting cancer within given organ systems - - Clear presentation by oncologists and radiologists of how histopathology, imaging, and pain monitoring can lead to new therapeutic approaches Benefit - Saves researchers and clinicians time in quickly accessing the very latest details on a broad range of bone cancer issues, as opposed to searching through thousands of journal articles. - Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system - Correct diagnosis (and therefore correct treatment) of cancer depends on a strong understanding of the molecular basis for the disease – both oncologists and radiologists will benefit - Bone biologists will gain insight into how clinical observations and practices can feed back into the research cycle and will, therefore, be able to develop more targeted genomic and proteomic assays |
| curative new berlin therapies: Functional Analytic Psychotherapy Mavis Tsai, Robert J. Kohlenberg, Jonathan W. Kanter, Gareth I. Holman, Mary Plummer Loudon, 2012-03-12 How can I supercharge the therapy I currently use? This volume distils the core principles, methods, and vision of the approach. Each Functional Analytic Psychotherapy (FAP) principle is presented in terms of its intended purpose and is clearly linked to the underlying theory, thus providing clinicians with a straightforward guide for when and how to apply each technique. FAP embraces awareness, courage, and love as integral to the treatment process. Part I of this volume reviews the history of FAP and the basic behavioral principles on which it is based. Part II provides an easy to use step-by-step guide to the application of FAP techniques. FAP is an approach undergoing a renaissance, and this volume uniquely summarizes the full history, theory, and techniques of FAP, resulting in a handbook perfect for clinicians and graduate students with or without a behavioural background. |
| curative new berlin therapies: Electroconvulsive and Neuromodulation Therapies Conrad M. Swartz, 2009-03-02 Electroconvulsive therapy (ECT) is a psychiatric treatment involving the induction of a seizure through the transmission of electricity in the brain. Because of exploitation movies and greatly heightened drug company promotional activities ECT was used less frequently in the 1980s and 1990s. Eventually these movies were understood as unrealistic. Now these drugs are increasingly recognized as dangers to body health. Because of recent refinements and a far better scientific understanding of the clinical procedures and mechanisms underpinning ECT, this treatment modality has seen a resurgence in use and widespread appreciation of its safety. This book is the new definitive reference on electroconvulsive and neuromodulation therapies. It comprehensively covers the scientific basis and clinical practice of ECT as well as comparisons between ECT and medication therapies including the new generation of antipsychotic drugs. It also provides readers with administrative perspectives and specific details for the management of this modality in clinical practice. The new forms of nonconvulsive electrical and magnetic brain stimulation therapy are also covered in detail, in a separate section. The chapter authors are leading scholars and clinicians. |
| curative new berlin therapies: Therapeutic Nuclear Medicine Richard P. Baum, 2014-08-16 The recent revolution in molecular biology offers exciting new opportunities for targeted radionuclide therapy. This up-to-date, comprehensive book, written by world-renowned experts, discusses the basic principles of radionuclide therapy, explores in detail the available treatments, explains the regulatory requirements, and examines likely future developments. The full range of clinical applications is considered, including thyroid cancer, hematological malignancies, brain tumors, liver cancer, bone and joint disease, and neuroendocrine tumors. The combination of theoretical background and practical information will provide the reader with all the knowledge required to administer radionuclide therapy safely and effectively in the individual patient. Careful attention is also paid to the role of the therapeutic nuclear physician in coordinating a diverse multidisciplinary team, which is central to the safe provision of treatment. |
| curative new berlin therapies: Childhood Cancer and Functional Impacts Across the Care Continuum National Academies of Sciences Engineering and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on Childhood Cancers and Disability, 2021-09-09 Since the late 1960s, the survival rate in children and adolescents diagnosed with cancer has steadily improved, with a corresponding decline in the cancer-specific death rate. Although the improvements in survival are encouraging, they have come at the cost of acute, chronic, and late adverse effects precipitated by the toxicities associated with the individual or combined use of different types of treatment (e.g., surgery, radiation, chemotherapy). In some cases, the impairments resulting from cancer and its treatment are severe enough to qualify a child for U.S. Social Security Administration disability benefits. At the request of Social Security Administration, Childhood Cancer and Functional Impacts Across the Care Continuum provides current information and findings and conclusions regarding the diagnosis, treatment, and prognosis of selected childhood cancers, including different types of malignant solid tumors, and the effect of those cancers on childrenâ (TM)s health and functional capacity, including the relative levels of functional limitation typically associated with the cancers and their treatment. This report also provides a summary of selected treatments currently being studied in clinical trials and identifies any limitations on the availability of these treatments, such as whether treatments are available only in certain geographic areas. |
| curative new berlin therapies: Methods of Cancer Diagnosis, Therapy and Prognosis M. A. Hayat, 2008-11-21 Cancer is the leading cause of death, in the number of older cancer patients is after cardiovascular diseases, in the expected. Approximately, 77% of all types United States. A total of ? 1,399,790 new of cancers are diagnosed in persons of 55 cancer cases and ? 564,830 deaths were years and older. It was estimated that o- reported in the year 2006 in the country. third of the 559,650 cancer deaths in 2007 Approximately, one in every two men and in the United States were related to ov- one in every three women in the country weight or obesity, physical inactivity, and will have some type of cancer during nutrition, and thus could also be prevented their lifetime. Healthcare costs exceed (Am. Cancer Society, 2007). However, 1. 7 trillion dollars per year in the United in developed countries, including United States, which is ? 15% of the country’s States, the average person of 65 years can gross domestic product. expect to live another 15 years in a fairly Tobacco use is the most serious prevent- good health. Persons of 75 or 85 years old able cause of cancer. Tobacco use causes have an average expectancy of 10 and 6 cancer of the lung, throat, mouth, pancreas, years, respectively. urinary bladder, stomach, liver, kidney, and During the last three decades, intensive other types. Passive smoking causes lung clinical research has resulted in reduced cancer. |
| curative new berlin therapies: The Therapeutic Use of Ayahuasca Beatriz Caiuby Labate, Clancy Cavnar, 2013-11-22 This book presents a series of perspectives on the therapeutic potential of the ritual and clinical use of the Amazonian hallucinogenic brew ayahuasca in the treatment and management of various diseases and ailments, especially its role in psychological well-being and substance dependence. Biomedical and anthropological data on the use of ayahuasca for treating depression, PTSD, and substance dependence in different settings, such as indigenous contexts, neo-shamanic rituals, contemporary therapeutic circles, and in ayahuasca religions, in both South and North America, are presented and critiqued. Though multiple anecdotal reports on the therapeutic use of ayahuasca exist, there has been no systematic and dense reflection on the topic thus far. The book brings the therapeutic use of ayahuasca to a new level of public examination and academic debate. The texts in this volume stimulate discussion on methodological, ethical, and political aspects of research and will enhance the development of this emergent field of studies. |
| curative new berlin therapies: Combined Modality Therapy of Gastrointestinal Tract Cancer Peter Schlag, Peter Hohenberger, Urs Metzger, 2012-12-06 Modern surgical oncology is characterized by multimodal therapy. In recent years numerous therapeutic approaches of pre-, peri-, intra-and postoperative treatment have been in vestigated with regard to their use in combination with surgi cal intervention. It now is time to analyze and to define the state of our knowledge. For tumors of the gastrointestinal tract there are several encouraging therapeutic approaches, such as preop erative chemotherapy in esophageal and perioperative chemotherapy in colon cancer. For some special tumors, like anal carcinoma, we have clearly defined combined therapies which even now must be viewed as standard treatment. It is also time to demonstrate the results of several clini cal studies that have been conducted within the last few years that combined surgical efforts with pre- or postinter ventional chemotherapy or radiotherapy. It is necessary to evaluate whether these trials contribute to progress in onco logical therapy. The editors of this volume - surgeons at the university hospitals of Heidelberg and Zurich - must be given the mer it of achieving these goals. It was especially appropriate for the Department of Surgery in Heidelberg, in close coopera tion with the Comprehensive Cancer Center Heidelberg/ Mannheim, to prepare a review of our present knowledge of surgical oncology as it is in the tradition of attempting to combine different therapeutic approaches to cancer therapy. |
| curative new berlin therapies: Against Therapy Jeffrey Moussaieff Masson, 2012-07-10 In this ground-breaking and highly controversial book, Jeffrey Moussaieff Masson attacks the very foundations of modern psychotherapy from Freud to Jung, from Fritz Perls to Carl Rodgers. With passion and clarity, Against Therapy addresses the profession's core weaknesses, contending that, since therapy's aim is to change people, and this is achieved according to therapist's own notions and prejudices, the psychological process is necessarily corrupt. With a foreword by the eminent British psychologist Dorothy Rowe, this cogent and convincing book has shattering implications. |
| curative new berlin therapies: Neuroendocrine Cancer: New Insights for the Healthcare Professional: 2012 Edition , 2012-12-10 Neuroendocrine Cancer: New Insights for the Healthcare Professional / 2012 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Neuroendocrine Cancer in a compact format. The editors have built Neuroendocrine Cancer: New Insights for the Healthcare Professional / 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Neuroendocrine Cancer in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Neuroendocrine Cancer: New Insights for the Healthcare Professional / 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| curative new berlin therapies: New Developments in Expressive Arts Therapy Stephen K. Levine, Ellen G. Levine, 2017-06-21 This collection reflects on the theory and application of expressive arts today in therapy, education, research and social and ecological change. Bringing the understanding of expressive arts into its contemporary theoretical framework, the book reveals the expansion of the field from its initial focus on therapy alone into a diverse range of other areas of interest to therapists, educators, researchers and those interested in working for social and ecological change. The book also contains a selection of discursive writing, poetry and visual art, highlighting the importance of keeping artistic creativity at the heart of the field. With contributions from pioneering arts therapists, this will be vital reading for arts therapists and students in the field today. |
| curative new berlin therapies: New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors Ernst D. Kreuser, Peter M. Schlag, 2012-12-06 This volume focuses on new and exciting approaches in the molecular and clinical management of gastrointestinal tumors. The first part presents recent insights into carcinogenesis, including alterations in cyclins and adhesion receptors, molecular structures which might be new targets of gene therapy. The second part of the volume offers new diagnostic tools, such as receptors for gastrointestinal hormones, proliferation markers, tumor suppressor proteins, and the multiple drug resistance gene, predicting response to therapy and prognosis in gastrointestinal tumors. The third part gives an update of successful approaches in primary and secondary prevention of colorectal carcinoma. Nutritional factors and pharmacologic agents can clearly decrease the risk, and fecal occult blood tests and endoscopy can reduce the mortality in colorectal carcinoma. Laparoscopic staging with subsequent biopsy of suspicious lymph nodes provides essential information in esophageal and gastric cancer. In locally advanced gastric cancer, preoperative chemotherapy provides sufficient evidence to investigate this approach as compared to primary surgery. Standards have recently been established in the adjuvant treatment of patients with gastrointestinal carcinoma, and promising new drugs, including monoclonal antibodies, thymidylate synthase, and topoisomerase inhibitors, as well as taxoids, are currently being tested in phase I, II, and III trials of gastrointestinal tumors. |
| curative new berlin therapies: Colon Cancer: New Insights for the Healthcare Professional: 2013 Edition , 2013-07-22 Colon Cancer: New Insights for the Healthcare Professional: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Diagnosis and Screening. The editors have built Colon Cancer: New Insights for the Healthcare Professional: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Diagnosis and Screening in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Colon Cancer: New Insights for the Healthcare Professional: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| curative new berlin therapies: Locoregional Tumor Therapy Eric Van Cutsem, Thomas J. Vogl, Franco Orsi, Alberto Sobrero, 2014-11-10 Recent years have witnessed a renaissance in the use of locoregional tumor therapy as part of a multimodal therapeutic approach to a variety of solid tumors, and attempts are underway to define its value in the overall therapeutic strategy for individual tumor entities. This flourishing of interest in locoregional tumor therapy derives from a series of important new developments concerning methodology, drug treatments, and instrumentation. The resulting approaches include not only optimized locoregional chemotherapy and chemoembolization for hepatocellular carcinoma and other tumors, but also other “targeted” therapies such as stereotactic radiosurgery, radiofrequency ablation, intra-arterial administration of radiopharmaceuticals, and complex new methods of chemoembolization of liver metastases involving the use of multiagent chemotherapy in combination with targeted drugs, drug-eluting beads/microspheres, or nanoparticles. In addition, intraperitoneal and intrapleural therapies, e.g., cytoreduction plus hyperthermic intraperitoneal chemotherapy, are now a standard element of the strategy for a range of tumors. It is vital that practitioners have the necessary expertise in the use of these locoregional treatment methods and understand how to combine them optimally with modern systemic therapies. With that goal in mind, this book presents, in condensed form, the clinical results achieved using various locoregional tumor therapies. In so doing, it will allow the reader to rapidly retrieve the information on indications and effectiveness that is required for optimal integration of these highly effective therapies into modern, yet more complex treatment strategies. |
| curative new berlin therapies: Disposable Bioreactors II Dieter Eibl, Regine Eibl, 2013-12-17 Dynamic Single-Use Bioreactors Used in Modern Liter- and m3- Scale Biotechnological Processes: Engineering Characteristics and Scaling Up, by Christian Löffelholz, Stephan C. Kaiser, Matthias Kraume, Regine Eibl , Dieter Eibl. Orbitally Shaken Single-Use Bioreactors, by Wolf Klöckner, Sylvia Diederichs, Jochen Büchs. Therapeutic Human Cells: Manufacture for Cell Therapy/Regenerative Medicine by Christian van den Bos, Robert Keefe, Carmen Schirmaier, Michael McCaman. Fast Single-Use VLP Vaccine Productions Based on Insect Cells and the Baculovirus Expression Vector System: Influenza as Case Study by Regine Eibl, Nina Steiger, Sabine Wellnitz, Tiago Vicente, Corinne John, Dieter Eibl. Microbial High Cell Density Fermentations in a Stirred Single-Use Bioreactor by Thomas Dreher, Bart Walcarius, Ute Husemann, Franziska Klingenberg, Christian Zahnow, Thorsten Adams, Davy de Wilde, Peter Casteels, Gerhard Greller. Quorus Bioreactor: A New Perfusion-Based Technology for Microbial Cultivation by Sheena J. Fraser, Christian Endres. Cultivation of Marine Microorganisms in Single-Use Systems by Friederike Hillig, Maciej Pilarek, Stefan Junne, Peter Neubauer. Flexible Biomanufacturing Processes that Address the Needs of the Future by Bernhard Diel, Christian Manzke, Thorsten Peuker. An Approach to Quality and Security of Supply for Single-Use Bioreactors by Magali Barbaroux, Susanne Gerighausen, Heiko Hackel. A Risk Analysis for Production Processes with Disposable Bioreactors by Tobias Merseburger, Ina Pahl, Daniel Müller, Markus Tanner. |
| curative new berlin therapies: Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II Gianni Bonadonna, G. Mathe, S. E. Salmon, 2012-12-06 1978 Annual Plenary Meeting of the European Organization for Research on Treatment of Cancer, Paris, June 1978 |
| curative new berlin therapies: Adjuvant Therapy of Breast Cancer V Hans-Jörg Senn, Richard D. Gelber, Aron Goldhirsch, Beat Thürlimann, 2012-12-06 We often hear physicians, health care professionals, poli ticians, and patient advocates that nothing has happened in the treatment of breast cancer, since patients with breast cancer, the most frequent neoplastic condition in women in industrialized countries, are continuing to suffer relapse and succumb to this dreadful disease! This negativistic attitude does not seem to be justified, but, why is the transmission of clinical trial results into general practice, and with it progress, such a slow process? After many decades of frustrating stagnation of long-term survival expectations, in all stages of early, oper/lble breast cancer treated only by surgery and locoregional radio therapy, adjuvant systemic therapy (chemo- as well as endocrine treatments) clearly showed to significantly benefit in terms of disease-free and overall survival. This evolution has been extensively expounded on by the Worldwide Oxford Overview and the Expert Consensus Panel at the fourth International Conference 'on Adjuvant Therapy of Primary Breast Cancer in St. Gallen (Early Breast Cancer Trialists' Collaborative Group 1992; Glick et al. 1992). What has happened since then? During the past 3-5 years, several new concepts and treatment strategies have emerged and have been studied in various major breast cancer groups and treatment centers worldwide. Some of these can already be considered to assist in the primary treatment of operable breast cancer today, while others are . still undergoing clini,cal trials for better definition of their practical usefulness. |
| curative new berlin therapies: Duchenne Muscular Dystrophy: New Insights for the Healthcare Professional: 2013 Edition , 2013-07-22 Duchenne Muscular Dystrophy: New Insights for the Healthcare Professional: 2013 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Additional Research in a compact format. The editors have built Duchenne Muscular Dystrophy: New Insights for the Healthcare Professional: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Additional Research in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Duchenne Muscular Dystrophy: New Insights for the Healthcare Professional: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| curative new berlin therapies: Gene Therapy of Cancer Peter Walden, Uwe Trefzer, Wolfram Sterry, Farzin Farzaneh, 2012-12-06 The book provides a comprehensive overview of the current state, and the new concepts for the future directions of modern cancer therapy. Bringing together all the relevant aspects from basic and applied science, and the clinical experiences of this new direction in medicine, it is an up-to-date summary of the activities in the field and will be the basis for evaluating future progress in this area. |
| curative new berlin therapies: Cancer of the Lung Alan Weitberg, 2001-10-04 Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective deployment of treatment guidelines introduced by third party payers to improve clinical outcomes, even while lowering healthcare costs. |
| curative new berlin therapies: Kaplan and Sadock's Comprehensive Textbook of Psychiatry Benjamin J. Sadock, Virginia A. Sadock, Pedro Ruiz, 2017-05-11 50th Anniversary Edition The cornerstone text in the field for 50 years, Kaplan & Sadock's Comprehensive Textbook of Psychiatry has consistently kept pace with the rapid growth of research and knowledge in neural science, as well as biological and psychological science. This two-volume Tenth Edition shares the expertise of over 600 renowned contributors who cover the full range of psychiatry and mental health, including neural science, genetics, neuropsychiatry, psychopharmacology, and other key areas. It remains the gold standard of reference for all those who work with the mentally ill, including psychiatrists and other physicians, psychologists, psychiatric social workers, psychiatric nurses, and other mental health professionals. |
| curative new berlin therapies: Journal of the National Cancer Institute , 2013 |
| curative new berlin therapies: Behavior and Self-Similarity between Nano and Human Scales: From T-pattern and T-string Analysis (TPA) with THEME to T-Societies Magnus S. Magnusson, Gudberg K. Jonsson, Mariona Portell, M. Teresa Anguera, Maurizio Casarrubea, Frank Schwab, 2023-09-12 This project was inspired in the sixties by primatologist D. Morris’s “The Naked Ape”, Niko Tinbergen, K. Lorenz, and K. von Frisch ethological research rewarded in 1973 by a shared Nobel Prize in Medicine or Physiology and E. O. Wilson’s 1975 opus “Sociobiology”. Other important inspirations were B. F. Skinner’s work on probabilistic real-time contingencies, N. Chomsky’s on syntactic structure and creativity, H. Montagner’s on interactions in social insects and children, S. Duncan’s on turn-taking in human dyadic interactions, and Richard Dawkins’ on behavioral hierarchy and detection algorithms. Structured animal mass-societies (>104 individuals) are only found in insects and modern humans and understanding their similarities and differences became a major aim through a search for hidden interaction patterns. Existing multivariate and artificial neural network methods and models lacked adequate description and detection of complex real-time patterns requiring new mathematical time structure (1-D) models, now the T-system, with detection algorithms and software (THEME™). |
| curative new berlin therapies: Directory of Medical Rehabilitation Programs , 1995 |
| curative new berlin therapies: Overcoming the immune microenvironment of hepatocellular cancer Shishir Shetty, Frank Tacke, Amaia Lujambio, 2021-07-08 |
| curative new berlin therapies: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation Dominik Schneidawind, Everett Meyer, 2020-05-22 |
| curative new berlin therapies: A History of Psychiatry Edward Shorter, 1998-03-03 PPPP . . . To compress 200 years of psychiatric theory and practice into a compelling and coherent narrative is a fine achievement . . . . What strikes the reader [most] are Shorter's storytelling skills, his ability to conjure up the personalities of the psychiatrists who shaped the discipline and the conditions under which they and their patients lived.--Ray Monk The Mail on Sunday magazine, U.K. An opinionated, anecdote-rich history. . . . While psychiatrists may quibble, and Freudians and other psychoanalysts will surely squawk, those without a vested interest will be thoroughly entertained and certainly enlightened.--Kirkus Reviews. Shorter tells his story with immense panache, narrative clarity, and genuinely deep erudition.--Roy Porter Wellcome Institute for the History of Medicine. In A History of Psychiatry, Edward Shorter shows us the harsh, farcical, and inspiring realities of society's changing attitudes toward and attempts to deal with its mentally ill and the efforts of generations of scientists and physicians to ease their suffering. He paints vivid portraits of psychiatry's leading historical figures and pulls no punches in assessing their roles in advancing or sidetracking our understanding of the origins of mental illness. Shorter also identifies the scientific and cultural factors that shaped the development of psychiatry. He reveals the forces behind the unparalleled sophistication of psychiatry in Germany during the eighteenth and nineteenth centuries as well as the emergence of the United States as the world capital of psychoanalysis. This engagingly written, thoroughly researched, and fiercely partisan account is compelling reading for anyone with a personal, intellectual, or professional interest in psychiatry. |
| curative new berlin therapies: Eurythmy Therapy Rudolf Steiner, 2013-04-16 Created in 1911, eurythmy was developed for years as an artistic and educational discipline. Although Rudolf Steiner pointed out its healing aspects from the very beginning, it was only in 1921 that he gave a course of lectures that gave the art of eurythmy a vital new application. To the assembled eurythmists and doctors, he presented what one participant described as '...a complete and detailed method of eurythmy therapy, in which we could directly experience that even today the creative and therapeutic power of the word ... is still at work'.Steiner's comprehensive lectures, republished here in a thoroughly revised translation, describe the principles of therapeutic eurythmy, giving many specific exercises. Primarily intended for practising eurythmists, these lectures also contain much material of particular interest. Steiner reveals the intricacies of rhythmic interplay between human physiology and the life-forces in the world around us. He describes the qualities of language and the dynamism contained in the individual vowels and consonants, elucidating their relationship with eurythmical movements and human experience. Through such movements, individuals are able to access the healing etheric forces.The exercises, referred to by Steiner as 'inner gymnastics', contain enormous potential for psychological and physiological well-being. Gaining ever-wider recognition today, they complement conventional medicine, offering a therapeutic process concerned with mind, soul and body.This new edition of these important lectures - previously published under the title Curative Eurythmy - includes an appendix with reminiscences by early eurythmists, as well as additional commentary from Dr Walter Kugler. |
| curative new berlin therapies: Assessing the Economic Value of Anticancer Therapies Niels Neymark, 2012-12-06 With ever increasing demands on the constrained resources available for health care services, no one involved in decision making in health care can continue to ignore the economic costs of the services provided or the relative value for money offered by the available treatments. Economic evaluation has therefore become an important and indispensable tool for medical deci sion making, alongside the well-known methods for clinical eval uation. This is also true for cancer, despite the aura of sanctity often of surrounding this dreaded disease and the apparent willingness the general population to spend large sums in this area and do everything possible for the patients. In recent years, articles dealing with assessing the costs and benefits of various cancer treatments have begun to appear in scientific medical and eco nomic journals. This book provides a comprehensive survey and assessment of the current state of the art of economic evaluations and cost ana lyses in cancer. It gives an introduction to the methods available for economic evaluations, before surveying and assessing the available publications. Separate chapters are devoted to the most prevalent cancers, and in each chapter the current clinical prac tice and research problems are summarized in order to provide a background for the economic analyses. At the end, a summary assessment of the literature is provided along with some sugges tions for a future research agenda. |
| curative new berlin therapies: Neoplastic Diseases of the Blood Peter H. Wiernik, Janice P. Dutcher, Morie A. Gertz, 2018-03-15 The new edition of this textbook integrates the history, epidemiology, pathology, pathophysiology, therapeutics, and supportive care of modern neoplastic hematopathology. Now in its sixth edition, this classic and invaluable text brings together a team of internationally renowned experts and offers in-depth coverage of the complex interface between diagnosis and therapy. The textbook is divided into five major sections, with the first four covering the spectrum of hematologic neoplasia, including chronic leukemias and related disorders, acute leukemias, myeloma and related disorders, and lymphomas, and the fifth section covering a variety of topics in supportive care. Chapters are presented in an accessible and easy-to-read layout, providing updates on the tremendous progress made in the last decade in the understanding of the nature of hematologic malignancies and their treatment. Neoplastic Diseases of the Blood, Sixth Edition is an authoritative and indispensable resource for students, trainees, and clinicians, sure to distinguish itself as the definitive reference on this subject. |
| curative new berlin therapies: Cancer Stem Cells Otmar D. Wiestler, Bernhard Haendler, D. Mumberg, 2007-08-03 Cancer stem cells have originally been identified in leukemia and later in several solid tumor types. They have very different properties from the bulk of the tumor as they divide much more slowly and have very efficient drug resistance mechanisms. Current treatments might largely spare cancer stem cells. This book looks at recent developments in the field of cancer stem cells and the possible impact for the identification of novel treatment paradigms for cancer. |
| curative new berlin therapies: Pancreatic Cancer Sun-Whe Kim, Hiroki Yamaue, 2017-05-04 This book provides state of the art knowledge on a broad range of clinical issues in pancreatic cancer, covering topics from screening and pathophysiology to surgical treatments. In particular, the focus is on current controversies and on evidence-based surgical techniques. Further aspects considered include the management of precancerous lesions, diagnostic methods, perioperative care and nonsurgical treatment. The description of surgical methods is supported by many helpful illustrations and important technical issues are carefully addressed. Determination of resectability and extent of surgery is also discussed. Based on recent developments in surgical techniques, some surgeons are performing more and more radical operations. It is essential, however, that surgical strategy is based on the best available evidence and surgeons will find that this book offers valuable help in achieving this aim. In addition, it will be a great asset in clinical practice for all who are involved or interested in the management of pancreatic cancer. |
| curative new berlin therapies: Minimally Invasive Spine Intervention Jörg Jerosch, 2023-03-15 The expert knowledge on numerous established and innovative minimally invasive interventions on the spine is systematically and in detail summarized in this book. All chapters are consistently structured with special education, implementation of the intervention, complications, literature, reimbursement and a final conclusion with assessment of clinical relevance. The focus is on the practice: step-by-step the procedure is presented under the heading carrying out the intervention. The book is ideal for practitioners who want to benefit from the know-how of experienced colleagues or who are interested in new innovative procedures and for referring physicians who want to get an overview. This book is a translation of the original German 1st edition Minimalinvasive Wirbelsäulenintervention by Jerosch Jörg published by Springer-Verlag GmbH Germany, part of Springer Nature in 2019. The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com). A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation. Springer Nature works continuously to further the development of tools for the production of books and on the related technologies to support the authors. |
| curative new berlin therapies: Protocols for Elective Use of Life-Sustaining Treatments Steven H. Miles, Carlos Fernández Gómez, 2013-11-21 |
Challenges and implications for biopharmaceutical companies
Four key commercialization challenges for curative therapies This paper describes four key challenges manufacturers might face when commercializing curative therapies. Two of these …
Roadmap for Navigating Cell and Gene Therapy Value …
curative cell and gene therapies have launched, bringing new era of therapeutic options to patients. Despite their potential value, there remains significant uncertainty around value …
Examining New Payment Ideas for Curative Therapies
Examining New Payment Ideas for Curative Therapies Allison Inserro How can the health industry ensure that cutting-edge gene therapies and other curative treatments get to the patients that …
A tool to assist in the prioritisation of medicines in cancer …
The highest grades of the ESMO-MCBS in the curative setting are A and B and in the non-curative setting 5 and 4, which indicate a substantial magnitude of benefit. There are 5 forms …
APPROACHES & FUNDING NEW PAYMENT PRODUCTS: …
Europe. These products offer groundbreaking new opportunities to patients living with rare diseases or cancer, with the capacity of often one-time disease-modifying and potentially …
Regenerative Medicine Is Here: New Payment Models Key To …
Curative Gene And Cell Therapies Require Unique Thinking Regenerative medicines can address the underlying cause of disease, providing a persistent impact after one administra-tion. Such …
Curative-intent Metastasis-directed Therapies for …
its effectiveness in delaying the initiation of non-curative salvage hormonal therapy (HT) [20–22]. Together, this evidence highlights the pressing need to evaluate novel molecular imaging …
Is today’s pharmaceutical commercial model going extinct? Is
Additionally, this also likely would require new and potentially costly reporting capabilities to track payments. Commercial model disruptions Development With the entry of more one-time …
Cell & Gene Therapies - sipconline.net
These properties translate into curative therapies for a range of diseases that currently have no cure. • Cell therapy: Involves transplanting cells into a patient to replace or repair damaged …
Pediatric Concurrent Care - NHPCO
directed, curative treatments to enroll in hospice. With concurrent care, pediatric patients must still meet the six-month prognosis, but do not have to choose between disease-directed, curative …
Clinical Adoption of Advanced Therapies: Challenges and …
Special Topic Cluster Clinical Adoption of Advanced Therapies: Challenges and Opportunities Michaela Sharpe a, *, Jacqueline Barry b, Panos Kefalas b a Moare Solutions Ltd, 99 …
A roadmap for the future of hepatitis B therapy development
The development of curative therapies for chronic hepatitis B virus infections, which affect approximately 296 million people worldwide, is being intensively pursued in public and private …
Enabling safe and timely patient access to transformative …
The European Alliance for Transformative Therapies (TRANSFORM) was created to foster effective dialogue around cell and gene therapies and provide evidence-based policy …
The Effectiveness of Aquatic Group Therapy for Improving
3 Curative New Berlin Therapies, New Berlin, WI, USA 4 Children’s Services Center, University of Southern California, Los Angeles, CA, USA. J Autism Dev Disord (2017) 47:4006–4017 4007 …
Profile of Kairali Ayurvedic Healing Village
NEW DELHI – 110 074 TEL.: +91-11-65028307, 65028308, 26801803 & 26801805 ... Ayurvedic therapies are based on the fundamental principles of nature and the medicines & oils ... Berlin, …
Hepatitis C hospitalizations in Spain and impact of new …
and liver cancer. The advent of curative new antiviral therapies since year 2015 has dramatically improved the prognosis of HCV patients. The real-life clinical benefits at country level of these …
ESMO MCBS H Instructions
The highest possible grades of the ESMO-MCBS:H are A in the curative setting, and 5 for non-curative indications. Grades of A and B in the curative setting and 5 and 4 in the non-curative …
Curative cell and gene therapies and healthcare system …
To understand the extent of the disruption posed by anticipated curative cell and gene therapies, we assessed the current pipeline for curative treatments. Approximately 55% of trials for …
VALUING TRANSFORMATIVE THERAPIES - Alliance for …
cell and gene therapies and other regenerative medicine products. Analyzecurrent and potential payment and financing models to facilitate and improve access and adoption. Break down …
Fighting Post-COVID and ME/CFS development of curative …
%PDF-1.6 %âãÏÓ 1 0 obj > endobj 2 0 obj >stream Fighting Post-COVID and ME/CFS – development of curative therapies Carmen Scheibenbogen ...
Back to Sleep Tummy to Play - curative.org
%PDF-1.4 %âãÏÓ 401 0 obj > endobj xref 401 73 0000000016 00000 n 0000002324 00000 n 0000002471 00000 n 0000003036 00000 n 0000003648 00000 n 0000004191 00000 n …
The Role of Stop-Loss Insurance and Reinsurance in …
AND CURATIVE THERAPIES Gene therapies are a good example of the durable and curative therapies category. Using a variety of technologies, they seek to make targeted changes in …
Investigating Potential Market Failure with Curative Cell and …
With the availability of these curative therapies, incidence rates are only likely to further decrease, limiting any incentive for competition development, and increasing the ... continued approval of …
Gene Therapy: A New Hope in Sickle Cell Disease Treatment
treatment for management and limited curative options until the last few years. Gene therapy has emerged as a curative option for SCD, with two approved therapies available to SCD patients …
A curative combination cancer therapy achieves high …
hypothesis that a curative cancer therapy can be constructed on the basis of independently effective drugs having non-overlapping mechanisms of resistance, without synergistic …
Role of Centers of Excellence (COE) Networks in the Delivery …
Sep 21, 2018 · heralds a new wave of emerging curative cellular therapies for cancer; in these cases, for the treatment of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma …
ESMO MCBS H Instructions
The highest possible grades of the ESMO-MCBS:H are A in the curative setting, and 5 for non-curative indications. Grades of A and B in the curative setting and 5 and 4 in the non-curative …
Reviewing new challenges and opportunities for hepatitis B …
One promising new therapeutic approach is the use of immune-based therapies. These therapies aim to boost the host immune response to HBV and help the body clear the virus. Several …
One-and-done gene therapies - KPMG
the majority of these gene therapies target rare or ultra-rare. 2. monogenic. 3. diseases with . clear genetic drivers. Only a few, like those designed to treat Huntington’s disease, beta . …
New Curative Treatment Strategies and New Therapies for …
Title: New Curative Treatment Strategies and New Therapies for Type 1 Diabetes Created Date: 4/29/2025 6:25:10 AM
Breakthroughs and Barriers: Advancing Value-Based …
Transformative therapies are one-time treatments with expected long-term or even curative effects. Recent breakthroughs in transformative therapeutic innovation have included gene …
2020 TOP 10 HEOR TRENDS - ispor.org
NOVEL CURATIVE THERAPIES . 6 . TREND . 4. OVERALL HEALTHCARE SPENDING . 7. TREND . 5. UNIVERSAL HEALTH COVERAGE— 8. ACCESS AND EQUITY. TREND . 6. …
Pharma intelligence | New Payment And Financing Models …
curative new therapies. Although an innovator may prefer to have the full value of the therapy recognized and compensated at the time of administra-tion, payers, providers and patients …
Are Global Health Systems Ready for Transformative Therapies?
formative” and “curative” has entered the technology debate only over the past several years, this does not mean that therapies that are transformative have emerged only during the past 2 to 4 …
Perineural Invasion in Pancreatic Ductal Adenocarcinoma …
10178 Berlin, Germany 3 Institute of Biometry and Clinical Epidemiology, Campus Charit éMitte, Charit -Universitätsmedizin Berlin, 10117 Berlin, Germany; dario.zocholl@charite.de 4 …
Frames Of Reference In Aqua Therapy - eliteminds.llc
Vol:.(1234567890) J Autism Dev Disord (2017) 47:4006 4017 DOI 10.1007/s10803-017-3264-4. 1 3. ORIGINAL PAPER. The E ectiveness of Aquatic Group Therapy for Improving
Locoregional Therapies for HCC. When Two Therapies May …
•Getting patients to curative outcomes should be our north star •Advancements in both locoregional (Y-90 personalized dosimetry, ablation modalities, etc…) and systemic therapies …
MAY/JUNE 2019 VOL. 5, NO. 3 VALUE & OUTCOMES …
curative therapies. One of our articles characterizes curative therapies as presenting new issues to old problems in HTA, while another encourages us to rethink the concept of value beyond …
ORIGINAL RESEARCH Curative Effect of Bracketless and …
ALTERNATIVE THERAPIES, [E-PUB AHEAD OF PRINT] This article is protected by copyright. To share or copy this article, please visit copyright.com. Use ISSN#1078-6791. To subscribe, …
The Practice of Functional Analytic Psychotherapy - InterContext
permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly …
Breakthroughs in Hepatocellular Carcinoma Therapies
where several new agents are now available in the first-and second-line setting, including immune checkpoint in-hibitor combinations. Objective responses are observed in ... ablative …
2020 TOP 10 HEOR TRENDS - ISPOR
NOVEL CURATIVE THERAPIES . 6 . TREND . 4. OVERALL HEALTHCARE SPENDING . 7. TREND . 5. UNIVERSAL HEALTH COVERAGE— 8. ACCESS AND EQUITY. TREND . 6. …
PROMOTING CLEAR AND EVIDENCE-BASED …
Evaluation form 1a: for RCTs evaluating new approaches to new potentially curative therapies Evaluation form 1b: for single arm therapies with curative intent and de-escalation studies …
Designing financial solutions to ensure affordable access to …
Aug 23, 2018 · therapies are difficult to assess (7). With growing numbers of cell- and gene-based therapies expected to be approved soon, there is an urgent need for new financing and …
Growth of Value-Based Purchasing and Contracting for Cell
cells a new set of instructions that can help them find and fight cancer. The Alliance for Cancer Gene Therapy says there is an urgent need to translate the profound success of CAR T …
Financing models for durable and potentially curative …
curative therapies: • Some payers may have challenges paying for a new treatment all at the same time, either because they are a smaller payer or because there are a large number of …
‘Potentially curative therapies for hepatocellular carcinoma:
ARTICLE OPEN Clinical Studies ‘Potentially curative therapies’ for hepatocellular carcinoma: how many patients can actually be cured? Alessandro Cucchetti1,2, Omar Elshaarawy3, Guohong …
ORIGINAL RESEARCH A Clinical Study on Chinese Five …
According to the curative effect judging criteria of “Guiding Principles of Clinical Research of New Chinese Medicines,” the curative effect of insomnia after 4 weeks of treatment was compared …
ORIGINAL RESEARCH Comparative Efficacy of Curative Effects …
ALTERNATIVE THERAPIES, [E-PUB AHEAD OF PRINT] Li—Comparative Efficacy of Sacubitril/Valsartan in HFPEF vs. HFREF This article is protected by copyright. To share or …
SPOTLIGHT EXTRA
innovative technology – and curative therapies – are changing the way we think about value models in healthcare. VOS: As we introduce new innovative technologies—for example cell …
